Fact checked byGina Brockenbrough, MA

Read more

October 20, 2024
1 min read
Save

Smith & Nephew partners with JointVue for ultrasound, robotic-assisted surgery planning

Fact checked byGina Brockenbrough, MA
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Key takeaways:

  • Smith & Nephew announced a co-marketing agreement for the OrthoSonic 3D surgery planning technology from JointVue.
  • The device uses ultrasound guidance for preoperative planning of robotic-assisted knee surgery.

Smith & Nephew announced a co-marketing agreement for the OrthoSonic 3D surgery planning technology from JointVue, according to a company press release.

“JointVue’s OrthoSonic technology allows surgeons and patients to get a 3D look inside their knee at the clinic in minutes without radiation — replacing a trip to the imaging center as they get ready for surgery,” Steven MacDonald, MD, CEO of JointVue, said in the release. “The 3D image and automated planning tool helps orthopedic surgeons personalize the procedure uniquely for each patient.”

Acquisition
Smith & Nephew announced a co-marketing agreement for the OrthoSonic 3D surgery planning technology from JointVue. Image: Adobe Stock

The OrthoSonic 3D technology from JointVue uses ultrasound guidance for preoperative planning of robotic-assisted knee arthroplasty procedures. According to the release, the device is compatible with the CORI surgical system from Smith & Nephew.

“The addition of JointVue’s technology further expands the imaging modalities available to Smith & Nephew customers for [preoperative] robotic planning,” Mayank Shandil, global senior vice president of reconstruction and robotics marketing for Smith & Nephew, said in the release. “The combination of JointVue with the CORI surgical system for robotic-assisted knee replacement provides a personalized solution for surgeons and patients and is a perfect fit for the growing ASC market.”